| SSP086 Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free (PDF:193KB) | 19 December 2025 to 06 February 2026 This SSP was withdrawn early on 23 January 2026 | Latanoprost 50micrgrams/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free supporting guidance plus Q&A (PDF:120KB) |
| SSP085 Adipine® XL 60mg MR tablets (PDF:199KB) | 19 December 2025 to 06 February 2026 This SSP was withdrawn early on 23 January 2026
| Adipine® XL 60mg MR tablets supporting guidance plus Q&A (PDF:126KB) |
| SSP084 Adipine® XL 30mg MR tablets (PDF:199KB) | 19 December 2025 to 06 February 2026 This SSP was withdrawn early on 23 January 2026
| Adipine® XL 30mg MR tablets supporting guidance plus Q&A (PDF:125KB) |
| SSP083 Venlafaxine 37.5mg modified release tablet (PDF:156KB) | 23 June 2025 to 01 August 2025 This SSP was withdrawn early on 22 July 2025 | Venlafaxine 37.5mg modified release tablet supporting guidance plus Q&A (PDF:114KB) |
| SSP078 Cefalexin 250mg/5ml oral suspension sugar free (PDF:143KB) | 08 May 2025 to 28 November 2025 | Cefalexin 250mg/5ml oral suspension sugar free supporting guidance plus Q&A (PDF:137KB) |
| SSP077 Cefalexin 125mg/5ml oral suspension sugar free (PDF:143KB) | 10 December 2024 to 28 November 2025 | Cefalexin 125mg/5ml oral suspension sugar free supporting guidance plus Q&A (PDF:136KB) |
| SSP076 Nyzamac® SR 60mg capsules (PDF:162KB) | 06 September 2024 to 8 November 2024 | Nyzamac® SR 60mg capsules supporting guidance plus Q&A (PDF:146KB) |
| SSP075 Monomil® XL 60mg tablets (PDF:162KB) | 06 September 2024 to 17 January 2025 | Monomil® XL 60mg tablets supporting guidance plus Q&A (PDF:146KB) |
| SSP074 Monomax® XL 60mg tablets (PDF:162KB) | 06 September 2024 to 15 November 2024 | Monomax® XL 60mg tablets supporting guidance plus Q&A (PDF:146KB) |
| SSP073 Chemydur® 60XL tablets (PDF:163KB) | 06 September 2024 to 11 October 2024 | Chemydur® 60XL tablets supporting guidance plus Q&A (PDF:145KB) |
| SSP072 Cefalexin 500mg tablets (PDF:138KB) | 06 August 2024 to 27 September 2024 | Cefalexin 500mg tablets supporting guidance plus Q&A (PDF:114KB) |
| SSP071 Ramipril 2.5mg tablets (PDF:139KB) | 06 August 2024 to 29 November 2024 | Ramipril 2.5mg tablets supporting guidance plus Q&A (PDF:114KB) |
| SSP070 Quetiapine 300mg tablets substitution and restriction (PDF:201KB) | 16 July 2024 to 13 September 2024 | Quetiapine 300mg tablets substitution and restriction supporting guidance plus Q&A (PDF:131KB) |
| SSP069 Quetiapine 300mg tablets restriction (PDF:202KB) | 16 July 2024 to 13 September 2024 | Quetiapine 300mg tablets restriction supporting guidance plus Q&A (PDF:124KB) |
| SSP068 Quetiapine 300mg tablets substitution (PDF:204KB) | 16 July 2024 to 13 September 2024 | Quetiapine 300mg tablets substitution supporting guidance plus Q&A (PDF:149KB) |
| SSP067 Quetiapine 200mg tablets substitution and restriction (PDF:203KB) | 16 July 2024 to 13 September 2024 | Quetiapine 200mg tablets substitution and restriction supporting guidance plus Q&A (PDF:133KB) |
| SSP066 Quetiapine 200mg tablets restriction (PDF:202KB) | 16 July 2024 to 13 September 2024 | Quetiapine 200mg tablets restriction supporting guidance plus Q&A (PDF:122KB) |
| SSP065 Quetiapine 200mg tablets substitution (PDF:205KB) | 16 July 2024 to 13 September 2024 | Quetiapine 200mg tablets substitution supporting guidance plus Q&A (PDF:151KB) |
| SSP064 Quetiapine 150mg tablets substitution and restriction (PDF:204KB) | 16 July 2024 to 13 September 2024 | Quetiapine 150mg tablets substitution and restriction supporting guidance plus Q&A (PDF:133KB) |
| SSP063 Quetiapine 150mg tablets restriction (PDF:203KB) | 16 July 2024 to 13 September 2024 | Quetiapine 150mg tablets restriction supporting guidance plus Q&A (PDF:123KB) |
| SSP062 Quetiapine 150mg tablets substitution (PDF:205KB) | 16 July 2024 to 13 September 2024 | Quetiapine 150mg tablets substitution supporting guidance plus Q&A (PDF:150KB) |
| SSP059 Monomil® XL 60mg tablets (PDF:164KB) | 26 Mar 2024 to 07 Jun 2024 | Monomil® XL 60mg tablets supporting guidance plus Q&A (PDF:150KB) |
| SSP058 Jext® 300micrograms/0.3ml (1 in 1000) solution for injection auto-injector pen (PDF:200KB) | 21 Aug 2023 to 27 Oct 2023 | Jext® 300mcg auto-injector supporting guidance plus Q&A (PDF:122KB) |
| SSP057 Estradot® 100mcg patches (PDF:218KB) | 21 Aug 2023 to 08 Dec 2023 | Estradot® 100mcg patches supporting guidance plus Q&A (PDF:117KB) |
| SSP056 Utrogestan® 100mg capsules (PDF:193KB) | 19 May 2023 to 29 Sept 2023 | Utrogestan® 100mg capsules supporting guidance plus Q&A (PDF:123KB) |
| SSP055 Estradot® 75mcg patches (PDF:216KB) | 13 Apr 2023 to 5 May 2023 | Estradot® 75mcg patches supporting guidance plus Q&A (PDF:114KB) |
| SSP054 Clarithromycin 250mg/5ml oral suspension (PDF:150KB) | 22 May 2024 to 19 July 2024 This SSP was reactivated | Clarithromycin 250mg/5ml oral suspension supporting guidance plus Q&A (PDF:115KB) |
| SSP053 Clarithromycin 125mg/5ml oral suspension (PDF:147KB) | 22 May 2024 to 19 July 2024 This SSP was reactivated | Clarithromycin 125mg/5ml oral suspension supporting guidance plus Q&A (PDF:116KB) |
| SSP052 Progynova® TS 100mcg patches (PDF:217KB) | 28 Mar 2023 to 8 Sep 2023
This SSP was withdrawn early on 25 Aug 2023. | Progynova® TS 100mcg patches supporting guidance plus Q&A (PDF:133KB) |
| SSP051 Paracetamol 240mg suppositories (PDF:142KB) | 17 Mar 2023 to 12 May 2023 | Paracetamol 240mg suppositories supporting guidance plus Q&A (PDF:111KB) |
| SSP050 Paracetamol 120mg suppositories (PDF:143KB) | 16 Feb 2023 to 12 May 2023 | Paracetamol 120mg suppositories supporting guidance plus Q&A (PDF:111KB) |
| SSP049 Estradot® 100mcg patches (PDF:205KB) | 25 Jan 2023 to 17 March 2023 This SSP was amended on 16 Feb 2023 | Estradot® 100mcg supporting guidance plus Q&A (PDF:114KB) |
| SSP048 Estradot® 50mcg patches (PDF:205KB) | 25 Jan 2023 to 24 February 2023 This SSP was amended on 16 Feb 2023 | Estradot® 50mcg supporting guidance plus Q&A (PDF:113KB) |
| SSP047 Phenoxymethylpenicillin 250mg tablets (PDF:272KB) | 16 Dec 2022 to 12 May 2023 This SSP was amended on 31 Jan 2023 | Phenoxymethylpenicillin 250mg tablets supporting guidance plus Q&A (PDF:238KB) |
| SSP046 Phenoxymethylpenicillin 250mg/5ml oral solution sugar free (PDF:274KB) | 16 Dec 2022 to 12 May 2023 This SSP was amended on 31 Jan 2023 | Phenoxymethylpenicillin 250mg/5ml sugar free supporting guidance plus Q&A (PDF:240KB) |
| SSP045 Phenoxymethylpenicillin 250mg/5ml oral solution (PDF:274KB) | 16 Dec 2022 to 12 May 2023 This SSP was amended on 31 Jan 2023 | Phenoxymethylpenicillin 250mg/5ml supporting guidance plus Q&A (PDF:237KB) |
| SSP044 Phenoxymethylpenicillin 125mg/5ml oral solution sugar free (PDF:275KB) | 16 Dec 2022 to 12 May 2023 This SSP was amended on 31 Jan 2023 | Phenoxymethylpenicillin 125mg/5ml sugar free supporting guidance plus Q&A (PDF:239KB) |
| SSP043 Phenoxymethylpenicillin 125mg/5ml oral solution (PDF:273KB) | 16 Dec 2022 to 12 May 2023 This SSP was amended on 31 Jan 2023 | Phenoxymethylpenicillin 125mg/5ml supporting guidance plus Q&A (PDF:237KB) |
| SSP042 Phenoxymethylpenicillin 250mg/5ml oral solution (PDF:143KB) | 15 Dec 2022 to 12 May 2023 | Phenoxymethylpenicillin 250mg/5ml supporting guidance plus Q&A (PDF:123KB) |
| SSP041 Phenoxymethylpenicillin 250mg/5ml oral solution sugar free (PDF:145KB) | 15 Dec 2022 to 12 May 2023 | Phenoxymethylpenicillin 250mg/5ml sugar free supporting guidance plus Q&A (PDF:128KB) |
| SSP040 Phenoxymethylpenicillin 125mg/5ml oral solution sugar free (PDF:138KB) | 15 Dec 2022 to 12 May 2023 | Phenoxymethylpenicillin 125mg/5ml sugar free supporting guidance plus Q&A (PDF:116KB) |
| SSP039 atorvastatin (Lipitor®)20mg chewable tablets (PDF:150KB) | 23 Nov 2022 to 03 Feb 2023 This SSP was withdrawn early on 27 January 2023 | Atorvastatin supporting guidance plus Q&A (PDF:118KB) |
| SSP038 Estraderm MX® 75mcg patches substitution (PDF:214KB) | 15 Nov 2022 to 27 Jan 2023 | Estraderm MX® 75mcg supporting guidance plus Q&A (PDF:114KB) |
| SSP037 Estraderm MX® 50mcg patches substitution (PDF:214KB) | 15 Nov 2022 to 13 Jan 2023 This SSP was withdrawn early on 23 Nov 2022 | Estraderm MX® 50mcg supporting guidance plus Q&A (PDF:114KB) |
| SSP036 Estraderm MX® 100mcg patches (PDF:214KB) | 08 Sep 2022 to 27 Jan 2023 | Estraderm MX® 100mcg supporting guidance plus Q&A (PDF:115KB) |
| SSP035 Estraderm MX® 25mcg patches (PDF:213KB) | 08 Sep 2022 to 14 Oct 2022 | Estraderm MX® 25mcg supporting guidance plus Q&A (PDF:114KB) |
| SSP034 Combisal® 125mcg/25mcg inhalers (PDF:146KB) | 22 Jul 2022 to 7 Oct 2022 | Combisal® 125mcg/25mcg inhalers supporting guidance plus Q&A (PDF:153KB) |
| SSP033 Paracetamol 120mg suppositories (PDF:139KB) | 31 May 2022 to 26 Aug 2022 | Paracetamol 120mg suppositories supporting guidance plus Q&A (PDF:111KB) |
| SSP032 Atorvastatin (Lipitor®) 10mg chewable tablets (PDF:145KB) | 31 May 2022 to 12 May 2023 | Atorvastatin (Lipitor®) 10mg chewable tablets supporting guidance plus Q&A (PDF:117KB) |
| SSP031 Estradiol (Sandrena®) 0.5mg and 1mg gel sachets substitution and restriction (PDF:751KB) | 19 May 2022 to 12 May 2023 | Sandrena® supporting guidance plus Q&A (PDF:185KB) |
| SSP030 Estradiol (Sandrena®) 0.5mg and 1mg gel sachets substitution (PDF:751KB) | 19 May 2022 to 12 May 2023 | Sandrena® supporting guidance plus Q&A (PDF:183KB) |
| SSP029 Estradiol (Sandrena®) 0.5mg and 1mg gel sachets restriction (PDF:600KB) | 19 May 2022 to 12 May 2023 | Sandrena® supporting guidance plus Q&A (PDF:130KB) |
| SSP028 Estradiol (Lenzetto®)1.53mg/dose transdermal spray substitution and restriction (PDF:749KB) | 19 May 2022 to 13 January 2023 | Lenzetto® supporting guidance plus Q&A (PDF:147KB) |
| SSP027 Estradiol (Lenzetto®)1.53mg/dose transdermal spray substitution (PDF:748KB) | 19 May 2022 to 13 January 2023 | Lenzetto® supporting guidance plus Q&A (PDF:146KB) |
| SSP026 Estradiol (Lenzetto®)1.53mg/dose transdermal spray restriction (PDF:601KB) | 19 May 2022 to 13 January 2023 | Lenzetto® supporting guidance plus Q&A (PDF:128KB) |
| SSP025 Estriol (Ovestin® 1mg cream) 0.1% cream substitution and restriction (PDF:228KB) | 19 May 2022 to 30 Nov 2022 | Ovestin® supporting guidance plus Q&A (PDF:152KB) |
| SSP024 Estriol (Ovestin® 1mg cream) 0.1% cream substitution (PDF:226KB) | 19 May 2022 to 30 Nov 2022 | Ovestin® supporting guidance plus Q&A (PDF:133KB) |
| SSP023 Estradiol (Oestrogel® Pump-Pack 0.06% gel) 0.06% gel (750microgram per actuation) substitution and restriction (PDF:751KB) | 19 May 2022 to 30 Nov 2022 | Oestrogel® supporting guidance plus Q&A (PDF:150KB) |
| SSP022 Estradiol (Oestrogel® Pump-Pack 0.06% gel) 0.06% gel (750microgram per actuation) substitution (PDF:750KB) | 19 May 2022 to 30 Nov 2022 | Oestrogel® supporting guidance plus Q&A (PDF:149KB) |
| SSP021 Premique® low dose 0.3mg/1.5mg modified-release tablets (PDF:166KB) | 29 Apr 2022 to 29 Jul 2022 | Premique® low dose supporting guidance plus Q&A (PDF:122KB) |
| SSP020 Ovestin® 1mg cream restriction (PDF:166KB) | 29 Apr 2022 to 30 Nov 2022 | Ovestin® supporting guidance plus Q&A (PDF:122KB) |
| SSP019 Oestrogel® Pump-Pack 0.06% gel restriction (PDF:167KB) | 29 Apr 2022 to 30 Nov 2022 | Oestrogel® supporting guidance plus Q&A (PDF:125KB) |
| SSP018 Salazopyrin® 500mg tablets (PDF:244KB) | 16 Mar 2022 to 25 Mar 2022 | Salazopyrin® supporting guidance plus Q&A (PDF:112KB) |
| SSP017 Atorvastatin (Lipitor®) 20mg chewable tablets (PDF:122KB) | 15 Feb 2022 to 5 Apr 2022 | Atorvastatin supporting guidance plus Q&A (PDF:111KB) |
| SSP016 Atorvastatin (Lipitor®) 10mg chewable tablets (PDF:123KB) | 15 Feb 2022 to 18 Mar 2022 | Atorvastatin supporting guidance plus Q&A (PDF:111KB) |
| SSP015 Paracetamol 120mg and 240mg suppositories (PDF:124KB) | 25 Jan 2022 to 4 Mar 2022 | Paracetamol supporting guidance plus Q&A (PDF:111KB) |
| SSP014 Salazopyrin® 500mg EN tablets (PDF:160KB) | 28 Feb 2022 to 1 Apr 2022 This SSP was reactivated. | Salazopyrin® EN supporting guidance plus Q&A (PDF:111KB) |
| SSP014 Salazopyrin® 500mg EN tablets (PDF:160KB) | 26 Nov 2021 to 21 Jan 2022 | Salazopyrin® EN supporting guidance plus Q&A (PDF:135KB) |
| SSP013 Atorvastatin (Lipitor®) 20mg chewable tablets (PDF:211KB) | 18 Nov 2021 to 12 Jan 2022 | Atorvastatin supporting guidance plus Q&A (PDF: 134KB) |
| SSP012 Estradot® 75microgram patches (PDF:204KB) | 29 Apr 2021 to 11 Jun 2021 | Estradot® supporting guidance plus Q&A (PDF: 120KB) |
| SSP011 Competact 15mg/850mg tablets (PDF:170KB) | 24 Mar 2021 to 14 May 2021 | Competact supporting guidance plus Q&A (PDF: 113KB) |
| SSP010 Levothyroxine 12.5microgram tablets (PDF:143KB) | 3 Feb 2021 to 1 Apr 2021 | Levothyroxine supporting guidance plus Q&A (PDF: 111KB) |
| SSP009 Fluoxetine 40mg capsules (PDF:139KB) | 29 Jan 2021 to 17 May 2021 | Fluoxetine supporting guidance plus Q&A (PDF: 111KB) |
| SSP008 Salazopyrin 500mg EN tablets (PDF:151KB) | 20 Oct 2020 to 8 Mar 2021 | Salazopyrin EN supporting guidance plus Q&A (PDF: 130KB) |
| SSP007 Fluoxetine 30mg capsules (PDF:144KB) | 20 Oct 2020 to 28 Jul 2021 | Fluoxetine supporting guidance plus Q&A (PDF: 142KB) |
| SSP06 Fluoxetine 40mg capsules (PDF:135KB) | 20 May 2020 to 2 Oct 2020 | Fluoxetine supporting guidance plus Q&A (PDF: 111KB) |
| SSP005 Fluoxetine 10mg tablets (PDF:134KB) | 12 Mar 2020 to 31 March 2023 | Fluoxetine supporting guidance plus Q&A (PDF: 107KB) |
| SSP04 Haloperidol (Serenace) 500 microgram (mcg) capsules (PDF:107KB) | 23 Dec 2019 to 23 Mar 2020 | Haloperidol supporting guidance plus Q&A (PDF:125KB) |
| SSP03 Fluoxetine 40mg capsules (PDF:131KB) | 3 Oct 2019 to 20 Nov 2019 | Fluoxetine supporting endorsement guidance (PDF: 139KB) |
| SSP02 Fluoxetine 30mg capsules (PDF:124KB) | 3 Oct 2019 to 18 Dec 2019 This SSP has been varied - the revised end date is now 18 Dec 19, and supply in accordance with this SSP is now 1 x 10mg Fluoxetine capsule PLUS 1 x 20mg Fluoxetine capsule. | Fluoxetine supporting endorsement guidance (PDF: 139KB) |
| SSP01 Fluoxetine 10mg capsules (PDF:151KB) | 3 Oct 2019 to 25 Oct 2019 | Fluoxetine supporting endorsement guidance (PDF: 139KB) |
